Mano Michael

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
5
Insider Sells Sum
$53,026.81

Insider Activity of Mano Michael

According to the SEC Form 4 filings, Mano Michael, being in a position of

  1. SVP, General Counsel&Secretary at Karyopharm Therapeutics Inc.,
    оver the last 12 months, has bought 0 shares, and sold 24520 shares for $27,016,
    over all time since 2023-03-01, has bought 0 shares, and sold 35286 shares for $53,027.

The largest sale of all time was on 2023-03-01 and amounted to 6878 shares of Karyopharm Therapeutics Inc. for $20,835.

Biography of Mano Michael

No biography is available at this moment.

2024-09-04SaleKaryopharm Therapeutics Inc.
KPTI
SVP, General Counsel&Secretary
3,971
0.0032%
$0.72$2,866+4.49%
2024-03-01SaleKaryopharm Therapeutics Inc.
KPTI
SVP, General Counsel&Secretary
3,576
0.0032%
$1.20$4,291-14.29%
2024-02-29SaleKaryopharm Therapeutics Inc.
KPTI
SVP, General Counsel&Secretary
16,973
0.0155%
$1.17$19,858-12.07%
2023-09-01SaleKaryopharm Therapeutics Inc.
KPTI
SVP, General Counsel&Secretary
3,888
0.0034%
$1.33$5,176-24.26%
2023-03-01SaleKaryopharm Therapeutics Inc.
KPTI
SVP, General Counsel&Secretary
6,878
0.0059%
$3.03$20,835-55.02%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.